GenoDive Pharma Inc announced that it has received in an equity round of funding on May 31, 2024. The transaction included the participation from new investor I'rom Group Co., Ltd. The transaction has been approved by the extraordinary general meeting of shareholders and the company will issue the shares through third-party allotment method.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,766 JPY | -0.04% | +0.04% | +37.68% |
May. 31 | GenoDive Pharma Inc announced that it has received funding from I'rom Group Co., Ltd. | CI |
2023 | I'rom Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+37.68% | 208M | |
-19.11% | 8.35B | |
+69.83% | 4.36B | |
+14.64% | 2.9B | |
-2.80% | 2.64B | |
-15.27% | 1.75B | |
-59.82% | 1.61B | |
-16.57% | 1.5B | |
+21.70% | 1.25B | |
-50.86% | 997M |
- Stock Market
- Equities
- 2372 Stock
- News I'rom Group Co., Ltd.
- GenoDive Pharma Inc announced that it has received funding from I'rom Group Co., Ltd.